Skip to main content
. Author manuscript; available in PMC: 2021 Apr 23.
Published in final edited form as: Nat Protoc. 2021 Feb 15;16(3):1331–1342. doi: 10.1038/s41596-020-00467-0

Table 5. Applications of cell-mediated cytotoxicity assays.

Listed are examples of published assays to analyze cytotoxic effects mediated by different effector cells, illustrating the various uses of the flow cytometry assay.

Flow cytometry assay
Application Effector cells/drug Target cells Staining E:T ratio(s) Incubation time (h) Reference
T cell– mediated cytotoxicity NY-ESO–specific T cells Jurkat/A2K CFSE, CMTMR, propidium iodide 1.5:1 to 0.1:1 4 97
CD8+ T cells DoHH2, Karpas, Raji CFSE, 7-AAD 50:1 to 2.5:1 24 98
γδ T cells THP-1 CFSE, propidium iodide 20:1 to 1:1 4 39
NK cell– mediated cytotoxicity NK cells K562 CellTrace Violet Dye 1:1 5 45
NK cells K562 Annexin V, propidium iodide, BCECF 1:1 to 1:10 1 to 3 99
NK cells K562 DiO, propidium iodide 75:1 to 6.25:1 3 44
NK cells K562 DIOC18, 7-AAD 20:1 to 1:1 4 100
Macrophage-mediated cytotoxicity U937 IGROV1 CFSE, propidium iodide, CD89-phycoerythrin 2:1 to 1:1 2.5 101
Oncolytic virus–mediated cytotoxicity PBMCs, adenovirus expressing BiTE (EGFR×CD3) A431, A549 GFP, 7-AAD MOI = 20, E:T = 6:1 5 days 95
BiTE-mediated cytotoxicity CD3+ T cells enriched from PBMCs, BiTE (CEA×CD3) CHO, ASPC-1, BxPC3, HPAC, HPAF II, H727, LS174T, HT-29, MKN45, Pan0813, A549, PC3, BT474 Vybrant DiO, propidium iodide 10:1 to 1:2 Up to 72 102
ADCC PBMCs, NK92MI, trastuzumab BT-474, MCF-7, Hs578T CFSE, FVD/7-AAD/propidium iodide 1:1 to 1:20 Overnight 103

7-AAD, 7-amino-actinomycin D; ADCC, antibody-dependent cellular cytotoxicity; BCECF, 2’,7’-bis(carboxyethyl)-5(6)-carboxyfluorescein; BiTE, bispecific T-cell engager; CFSE, carboxyfluorescein succinimidyl ester; CMTMR, 5- and 6-([(4-chloromethyl)benzoyl]-amino) tetramethylrhodamine; E:T, effector to target; FVD, fixed viability dye; GFP, green fluorescent protein; MOI, multiplicity of infection; PBMC, peripheral blood mononuclear cell; NK, natural killer.